AUG 30, 2016 11:55 AM PDT

Breast Milk Sugar Protects Newborns From Streptococcus

WRITTEN BY: Kara Marker
While a newborn’s immune system is getting revved up after birth, a specific sugar in the mother’s breast milk seems to be protecting the newborn from bacteria in the meantime. 
Around 50 percent of women have lacto-n-difucohexaose I in their breast milk, along with various vitamins, fats, proteins, and many other types of sugar. From the Centre for International Child Health at Imperial College London, lead study researcher Dr. Nicholas Andreas and his team investigated the protective abilities of lacto-n-difucohexaose I in the face of Group B Streptococcus in 183 women from The Gambia. 

The study, published recently in the journal Clinical and Translational Immunology, involved testing the breast milk of the participants for sugars known to be controlled by genes from the Lewis antigen system, a gene system partly responsible for the diversity of sugars in a woman’s breast milk. The researchers also kept track of the presence of Group B Streptococcus in both the mothers and their infants at birth, six days after birth, and between 60 and 89 days after birth.

First, the researchers found women with breast milk sugars related to Lewis antigen system genes were the least likely to have Group B Streptococcus in their vagina and breast milk. Group B Streptococcus is the global leading cause of infection for newborns in the first three months of life and a common cause of meningitis in newborns. The bacteria occur naturally in the vagina and bowels of about one-third of all women, making them capable of transferring the bacteria to their infants during childbirth or via breast milk. 

For the mothers in the study with breast milk sugars related to Lewis antigen system genes, their infants were less likely than others to be exposed to Group B Streptococcus during childbirth or while breast feeding.  

The focus of the study finally landed on lacto-n-difucohexaose I when the researchers saw that even for infants who did receive Group B Streptococcus from their mothers, they were more likely to clear the bacteria from their body by day 60-89 after birth if their mothers also had lacto-n-difucohexaose in their breast milk (and the babies were being breast fed). 

Lacto-n-difucohexaose is also linked to Lewis antigen system genes, reinforcing what researchers knew about the protective effect of these genes, but the findings from the study also seemed to point toward a protective effect specific to the sugar, lacto-n-difucohexaose.

Andreas said that the research “demonstrates the complexity of breast milk, and the benefits it may have for the baby.”

After looking just at breast milk containing lacto-n-difucohexaose and its ability to kill Group B Streptococcus, the researchers saw that it killed the bacteria much more effectively than breast milk without the sugar.

"If we know whether a mother is colonised with Group B streptococcus and know if she carries an active copy of the Lewis gene,” Andreas explained. “It may give us an indication of how likely she is to pass the bacteria on to her baby, and more personalised preventive measures could be applied."

There is a test available to see if mothers contain Group B Streptococcus before they give birth, but the bacteria could always be encountered between the test and birth of the newborn.

Andreas’ research makes a valuable contribution to what scientists know about breast milk, an already intriguing biological occurrence. The variety of sugars found in breast milk, called human milk oligosaccharides, are not digested in the stomach of the newborn. Instead, the sugars provide nutrition for the newborn’s gut microbiota, the so-called “good bacteria” that live in the intestinal tract of all human beings. In addition to providing nourishment for good bacteria, scientists from the study believe that the sugars flush out bad bacteria by attracting them as the body excretes the sugars from the body.

Overall, this research could lead to new therapeutics for expecting mothers, maybe in the form of introducing lacto-n-difucohexaose into their bodies in the form of breast milk supplements as well as targeting women who lack the Lewis antigen system genes. 
 


Sources: Imperial College London, American Pregnancy Association 
Image: www.momjunction.com
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 27, 2019
Drug Discovery & Development
SEP 27, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
OCT 08, 2019
Immunology
OCT 08, 2019
Circadian Rhythm Governs Immune Protection of the Gut
The circadian rhythm governs more than just waking and sleeping. The intricate functions of the digestive system rely on the ticking, clock-like rhythm as ...
OCT 23, 2019
Immunology
OCT 23, 2019
Treating Celiac Disease May Be Possible
Delivering gluten to the body in a friendly, harmless package may be the way for people with celiac disease to finally have a sandwich again. A new clinica...
OCT 29, 2019
Immunology
OCT 29, 2019
Immune Protein Prevents Herpes Spreading to the Brain
An immune protein that was discovered more than two decades ago has been identified as the primary component of a molecular blockade that prevents genital ...
DEC 17, 2019
Immunology
DEC 17, 2019
Increased Belly Fat with Aging Linked to Reduced Mental Flexibility
Did you ever consider that your brain can flex similarly to the way your biceps can? Sure, brain flexing is more abstract and less literal, but the concept...
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
Loading Comments...